HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-amino-2-deoxyglucopyranosyl 2-acetamido-2-deoxyglucopyranose

Also Known As:

2-amino-2-deoxy-D-glucopyranosyl 2-acetamido-2-deoxy-D-glucopyranose; GlcN-GlcNAc

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Disaccharides: 990
      - 2-amino-2-deoxyglucopyranosyl 2-acetamido-2-deoxyglucopyranose: 1
- Sugars: 11126
  - Disaccharides: 990
    - 2-amino-2-deoxyglucopyranosyl 2-acetamido-2-deoxyglucopyranose: 1

Experts

1.	Nagaoka, Isao: 1 article (07/2020)
2.	Someya, Akimasa: 1 article (07/2020)
3.	Yamagishi, Yoshie: 1 article (07/2020)

Related Diseases

1.

Joint Diseases (Joint Disease)

07/01/2020 - "Furthermore, the combined effect of Cit, GlcNAc and GlcN was examined; Cit + GlcN and Cit + GlcNAc significantly suppressed not only IL-6 production, but also phosphorylation of ERK1/2. Similarly, combination of GlcN + GlcNAc significantly suppressed IL-6 production and phosphorylation of ERK1/2. These observations suggest that among Cit, GlcNAc and GlcN, the combination of Cit with GlcN or GlcNAc exerts a synergistic anti-inflammatory effect on synovial cells, thereby possibly exhibiting chondroprotective effects and alleviating inflammatory joint diseases."

Related Drugs and Biologics

1.	Interleukin-6 (Interleukin 6)
2.	serum P-component (CIt)